Skip to content

Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy

Effects of Preoperative Immunonutrition on Infectious Complication and Th1/Th2 Differentiation in Patients Undergoing Hepatectomy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01256047
Enrollment
40
Registered
2010-12-08
Start date
2009-05-31
Completion date
2014-03-31
Last updated
2020-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Cancer

Keywords

immunonutrition, hepatectomy, Th1, Th2

Brief summary

The purpose of this study is to determine whether preoperative immunonutrition is effective on infectious complication and Th1/Th2 differentiation in patients with major hepatectomy.

Detailed description

The investigators reported that preoperative immunonutrition improve the incidence of postoperative infectious complication in patients after hepatectomy, and modulation of Th1/Th2 differentiation may play important roles in this effect. Object of this study is to investigate the effects of preoperative immunonutrition on incidence of postoperative infectious complication, and Th1/Th2 balance after hepatectomy.

Interventions

DIETARY_SUPPLEMENTOral IMPACT

oral supplement for 5 days(1L/day) before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA

Sponsors

Chiba University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* hepatectomy

Exclusion criteria

* age younger than 18 years * ongoing infection * gastrointestinal obstruction * respiratory dysfunction * cardiac dysfunction * hepatic dysfunction * renal failure * history of recent immunosuppressive or immunological disease * preoperative evidence of widespread metastatic disease

Design outcomes

Primary

MeasureTime frame
postoperative infectious complication30 days

Secondary

MeasureTime frame
plasma IL-6, CRP, Th1/Th2 balance14 days

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026